Related references
Note: Only part of the references are listed.Trace amine-associated receptor 1: a multimodal therapeutic target for neuropsychiatric diseases
Michael D. Schwartz et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2018)
Role of Anterior Intralaminar Nuclei of Thalamus Projections to Dorsomedial Striatum in Incubation of Methamphetamine Craving
Xuan Li et al.
JOURNAL OF NEUROSCIENCE (2018)
Methamphetamine-induced impulsivity during chronic methamphetamine treatment in rats: Effects of the TAAR 1 agonist R05263397
Zhaoxia Xue et al.
NEUROPHARMACOLOGY (2018)
Trace Amine-Associated Receptor 1 Modulates the Locomotor and Sensitization Effects of Nicotine
Ilya Sukhanov et al.
FRONTIERS IN PHARMACOLOGY (2018)
TAAR1 in Addiction: Looking Beyond the Tip of the Iceberg
Jian-Feng Liu et al.
FRONTIERS IN PHARMACOLOGY (2018)
A Spontaneous Mutation in Taar1 Impacts Methamphetamine-Related Traits Exclusively in DBA/2 Mice from a Single Vendor
Cheryl Reed et al.
FRONTIERS IN PHARMACOLOGY (2018)
The Trace Amine-Associated Receptor 1 Agonist RO5256390 Blocks Compulsive, Binge-like Eating in Rats
Antonio Ferragud et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Genome-wide association study of alcohol consumption and genetic overlap with other health-related traits in UK Biobank (N=112117)
T-K Clarke et al.
MOLECULAR PSYCHIATRY (2017)
A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci
Diana Chang et al.
NATURE GENETICS (2017)
Parallel Effects of Methamphetamine on Anxiety and CCL3 in Humans and a Genetic Mouse Model of High Methamphetamine Intake
Marilyn Huckans et al.
NEUROPSYCHOBIOLOGY (2017)
Pharmacology of human trace amine-associated receptors: Therapeutic opportunities and challenges
Mark D. Berry et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Possible role of rare variants in Trace amine associated receptor 1 in schizophrenia
Jibin John et al.
SCHIZOPHRENIA RESEARCH (2017)
Association of the PLCB1 gene with drug dependence
Judit Cabana-Dominguez et al.
SCIENTIFIC REPORTS (2017)
Effects of chronic methamphetamine on psychomotor and cognitive functions and dopamine signaling in the brain
Panayotis K. Thanos et al.
BEHAVIOURAL BRAIN RESEARCH (2017)
Association of the OPRM1 Variant rs1799971 (A118G) with Non-Specific Liability to Substance Dependence in a Collaborative de novo Meta-Analysis of European-Ancestry Cohorts
Tae-Hwi Schwantes-An et al.
BEHAVIOR GENETICS (2016)
Meta-Analyses of Genome-Wide Association Data Hold New Promise for Addiction Genetics
Arpana Agrawal et al.
JOURNAL OF STUDIES ON ALCOHOL AND DRUGS (2016)
Analysis of protein-coding genetic variation in 60,706 humans
Monkol Lek et al.
NATURE (2016)
A Functional 3′UTR Polymorphism (rs2235749) of Prodynorphin Alters microRNA-365 Binding in Ventral Striatonigral Neurons to Influence Novelty Seeking and Positive Reward Traits
Gabor Egervari et al.
NEUROPSYCHOPHARMACOLOGY (2016)
A Mouse Model for Binge-Level Methamphetamine Use
Shkelzen Shabani et al.
FRONTIERS IN NEUROSCIENCE (2016)
Genetic Polymorphisms Affect Mouse and Human Trace Amine-Associated Receptor 1 Function
Xiao Shi et al.
PLOS ONE (2016)
In Vitro Characterization of Psychoactive Substances at Rat, Mouse, and Human Trace Amine-Associated Receptor 1
Linda D. Simmler et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
Recovery of dopamine transporters with methamphetamine detoxification is not linked to changes in dopamine release
Nora D. Volkow et al.
NEUROIMAGE (2015)
Trace Amine-Associated Receptor 1 Regulation of Methamphetamine Intake and Related Traits
John H. Harkness et al.
NEUROPSYCHOPHARMACOLOGY (2015)
Methamphetamine: An update on epidemiology, pharmacology, clinical phenomenology, and treatment literature
Kelly E. Courtney et al.
DRUG AND ALCOHOL DEPENDENCE (2014)
Amphetamine Modulates Excitatory Neurotransmission through Endocytosis of the Glutamate Transporter EAAT3 in Dopamine Neurons
Suzanne M. Underhill et al.
NEURON (2014)
Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: Role of D2 dopamine autoreceptors
D. Leo et al.
NEUROPHARMACOLOGY (2014)
Mesocorticolimbic monoamine correlates of methamphetamine sensitization and motivation
Kevin D. Lominac et al.
FRONTIERS IN SYSTEMS NEUROSCIENCE (2014)
The role of tyrosine metabolism in the pathogenesis of chronic migraine
Giovanni D'Andrea et al.
CEPHALALGIA (2013)
Methamphetamine use: A comprehensive review of molecular, preclinical and clinical findings
William J. Panenka et al.
DRUG AND ALCOHOL DEPENDENCE (2013)
A synonymous polymorphic variation in ACADM exon 11 affects splicing efficiency and may affect fatty acid oxidation
Gitte Hoffmann Bruun et al.
MOLECULAR GENETICS AND METABOLISM (2013)
Large candidate gene association study reveals genetic risk factors and therapeutic targets for fibromyalgia
Shad B. Smith et al.
ARTHRITIS AND RHEUMATISM (2012)
Opiate addiction and cocaine addiction: underlying molecular neurobiology and genetics
Mary Jeanne Kreek et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Brain-Specific Overexpression of Trace Amine-Associated Receptor I Alters Monoaminergic Neurotransmission and Decreases Sensitivity to Amphetamine
Florent G. Revel et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Genome-Wide Association Study of d-Amphetamine Response in Healthy Volunteers Identifies Putative Associations, Including Cadherin 13 (CDH13)
Amy B. Hart et al.
PLOS ONE (2012)
Augmentation of methamphetamine-induced behaviors in transgenic mice lacking the trace amine-associated receptor 1
Cindy Achat-Mendes et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2012)
Selection for Translation Efficiency on Synonymous Polymorphisms in Recent Human Evolution
Yedael Y. Waldman et al.
GENOME BIOLOGY AND EVOLUTION (2011)
Neurocircuitry of Addiction
George F. Koob et al.
NEUROPSYCHOPHARMACOLOGY (2010)
A brief measure for assessing generalized anxiety disorder -: The GAD-7
Robert L. Spitzer et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence
ND Volkow et al.
JOURNAL OF NEUROSCIENCE (2001)
The PHQ-9 - Validity of a brief depression severity measure
K Kroenke et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2001)
Share Paper
